The drug of Summer in the Southeast
Emergency medicine is dangerous work. Here’s a rundown of some of the greatest infection threats and their appropriate prophylactic agents
A target-specific oral anti-coagulant, dabigatran/Pradaxa™ proves that Warfarin isn’t the only game in town.
This fundamental building block of life will stop your heart — just long enough to be useful
Flu season is upon us. The decision to treat with a neuraminidase inhibitor requires a risk-benefit analysis, and for many patients, the risks of side effects and the cost may outweigh the potential benefits. A 2014 Cochrane review was finally able to evaluate previously unavailable data, and found neuraminidase inhibitors are not all we had hoped.
Class A morning sickness medication gains FDA approval after decades of being misunderstood
In this case study, a single administration of methylene blue resolved significant amyl nitrate intoxication and critical methemoglobinemia.
EMS brings in a two-year-old with vomiting and decreased mental status. According to their report, he had been doing well until he suddenly got sick en route to the hospital. He became sleepier, and, as they wheeled him in, he began to seize. His parents say he was at a relative’s house when he was found drinking from a container of some colorful liquid, which he accidently spilled on himself. Then he began to vomit. The culprit: the liquid was used to refill electronic cigarettes.
After a recent study of colchicine use for gout, the FDA approved its use and granted 3-year exclusive marketing rights to the company that performed the study, leading to a huge jump in the price.
In this new regular series, we’ll take a closer look at some of the drugs we use frequently in the ED. We aim to capture new indications for old standbys, or risks and dosing adjustments you should know, plus some unusual facts you might enjoy.